About MEDiC
MEDiC is a company based in San Carlos (United States) founded in 2019 by Hong-pyo Lee, Ki Eun Pyo, and Kyuho Han. MEDiC has raised $13 million across 2 funding rounds from investors including Illumina, LG Chem and Hanmi. The company has 9 employees as of December 31, 2022. MEDiC offers products and services including CRISPR Platform. MEDiC operates in a competitive market with competitors including Senti Biosciences, Poseida Therapeutics, ADARx Pharmaceuticals, CRISPR Therapeutics and Aldevron, among others.
- Headquarter San Carlos, United States
- Employees 9 as on 31 Dec, 2022
- Founders Hong-pyo Lee, Ki Eun Pyo, Kyuho Han
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medic Life Sciences
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Seed
Oct 14, 2024
-
Investors
Illumina
& 7 more
-
Employee Count
9
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MEDiC
MEDiC offers a comprehensive portfolio of products and services, including CRISPR Platform.
Tool for assessing cancer mutations in tumor models for drug development.
People of MEDiC
Unlock access to complete
Unlock access to complete
Funding Insights of MEDiC
MEDiC has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MEDiC
MEDiC has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, LG Chem and Hanmi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Startup acceleration and venture capital funding are provided.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for MEDiC
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MEDiC
Investment portfolio details for MEDiC
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MEDiC
Detailed financials for MEDiC
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medic Comparisons
Peer comparison for MEDiC
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MEDiC
MEDiC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Poseida Therapeutics, ADARx Pharmaceuticals, CRISPR Therapeutics and Aldevron, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell-based therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts
|
|
| Locked | Locked | Locked |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing.
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Therapeutics for molecular-level cancer treatment are developed.
|
Detailed competitors of MEDiC
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medic
Complete news archive for MEDiC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MEDiC
MEDiC was founded in 2019 and raised its 1st funding round 4 years after it was founded.
MEDiC is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Kyuho Han is the current CEO of MEDiC. They have also founded this company.
MEDiC is a funded company, having raised a total of $13M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at MEDiC is 9.
MEDiC was founded in 2019 and is based in San Carlos, United States, within the medical life sciences sector. CRISPRCas9 functional genomics tools are integrated into 3D cancer organoids tailored to specific cancer types. These organoids are used to replicate genetic mutations found in tumors, supporting research for clinical trials. Operations focus on advancing precision oncology models for therapeutic evaluation.
MEDiC's top competitors include CRISPR Therapeutics, Senti Biosciences and Poseida Therapeutics.
MEDiC offers CRISPR Platform.
MEDiC has 8 investors. Key investors include Illumina, LG Chem, Hanmi, Top Harvest Capital, and Primer Sazze Partners.